Skip to content

Bill Schiffner

CDC acts on NACDS’ concerns, removes RSV vax barrier

CDC acts on NACDS’ concerns, removes RSV vax barrier

Following timely outreach from NACDS on behalf of the industry, NACDS was pleased to see efficient action from the Centers for Disease Control and Prevention (CDC) and Centers for Medicare & Medicare Services (CMS) to help mitigate RSV (Respiratory Syncytial Virus) vaccine access challenges at pharm